These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20662774)

  • 1. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.
    El-Serag H; Becher A; Jones R
    Aliment Pharmacol Ther; 2010 Sep; 32(6):720-37. PubMed ID: 20662774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Becher A; El-Serag H
    Aliment Pharmacol Ther; 2011 Sep; 34(6):618-27. PubMed ID: 21770991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
    Kahrilas PJ; Howden CW; Hughes N
    Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: persistence and severity in gastro-oesophageal reflux disease.
    Armstrong D
    Aliment Pharmacol Ther; 2008 Oct; 28(7):841-53. PubMed ID: 18637097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
    Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
    Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Delshad SD; Almario CV; Chey WD; Spiegel BMR
    Gastroenterology; 2020 Apr; 158(5):1250-1261.e2. PubMed ID: 31866243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
    Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
    Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease.
    Boeckxstaens GE; Smout A
    Aliment Pharmacol Ther; 2010 Aug; 32(3):334-43. PubMed ID: 20491749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough.
    Kiljander TO
    Am J Med; 2003 Aug; 115 Suppl 3A():65S-71S. PubMed ID: 12928078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.
    Kahrilas PJ; Howden CW; Wernersson B; Denison H; Nuevo J; Gisbert JP
    Aliment Pharmacol Ther; 2013 May; 37(10):1005-10. PubMed ID: 23557078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease.
    Hungin AP; Hill C; Molloy-Bland M; Raghunath A
    Clin Gastroenterol Hepatol; 2012 Feb; 10(2):109-16. PubMed ID: 21782770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.